FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:992-996 September 23, 1999 Number 13 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

The recent use of sham surgery in randomized, controlled trials raises three critical questions about research involving human subjects. The first question concerns the tension between the highest standard of research design and the highest standard of ethics.¹ When these two standards come into conflict and researchers cannot simultaneously meet both, which should prevail, and how should a balance be struck? The second question points to ongoing uncertainties and disagreements in assessing the risks and benefits of research protocols. When reasonable people — the members of well-established institutional review boards or the sponsors of research — disagree in their risk–benefit . . . [Full Text of this Article]

Scientific and Ethical Standards

Assessing Risks and Benefits

Informed Consent in Research Involving Sham Surgery

Conclusions

References

This article has been cited by other articles:

• Kim, M. K., Lee, J.-L., Hyun, M. S., Do, Y. R., Song, H. S., Kim, J. G., Bae, S. H., Ryoo, H. M., Park, K. U., Lee, K. H. (2008). Palliative Chemotherapy Preferences and Factors that Influence Patient Choice in Incurable Advanced Cancer. Jpn J Clin Oncol 0: hym147v1-7 [Abstract] [Full Text]  
• Stern, P. J. (2007). Hattage. JBJS 89: 2803-2809 [Full Text]  
• Sutherland, E. R. (2007). Sham Procedure versus Usual Care as the Control in Clinical Trials of Devices: Which is Better?. Proc Am Thorac Soc 4: 574-576 [Abstract] [Full Text]  
• Mehta, S., Myers, T. G., Lonner, J. H., Huffman, G. R., Sennett, B. J. (2007). The Ethics of Sham Surgery in Clinical Orthopaedic Research. JBJS 89: 1650-1653 [Full Text]  
• Master, Z., McLeod, M., Mendez, I. (2007). Benefits, risks and ethical considerations in translation of stem cell research to clinical applications in Parkinson's disease. J. Med. Ethics 33: 169-173 [Abstract] [Full Text]  
• Kim, S.Y.H., Holloway, R. G., Frank, S., Beck, C. A., Zimmerman, C., Wilson, R., Kieburtz, K. (2006). Volunteering for early phase gene transfer research in Parkinson disease. Neurology 66: 1010-1015 [Abstract] [Full Text]  
• Rascol, O. (2005). Assessing the risk of a necessary harm: Placebo surgery in Parkinson disease. Neurology 65: 982-983 [Full Text]  
• Frank, S., Kieburtz, K., Holloway, R., Kim, S. Y.H. (2005). What is the risk of sham surgery in Parkinson disease clinical trials? A review of published reports. Neurology 65: 1101-1103 [Abstract] [Full Text]  
• Woods, S. W., Gueorguieva, R. V., Baker, C. B., Makuch, R. W. (2005). Control Group Bias in Randomized Atypical Antipsychotic Medication Trials for Schizophrenia. Arch Gen Psychiatry 62: 961-970 [Abstract] [Full Text]  
• Kim, S. Y. H., Frank, S., Holloway, R., Zimmerman, C., Wilson, R., Kieburtz, K. (2005). Science and Ethics of Sham Surgery: A Survey of Parkinson Disease Clinical Researchers. Arch Neurol 62: 1357-1360 [Abstract] [Full Text]  
• Albin, R L (2005). Sham surgery controls are mitigated trolleys. J. Med. Ethics 31: 149-152 [Abstract] [Full Text]  
• Miller, F. G, Kaptchuk, T. J (2004). Sham procedures and the ethics of clinical trials. JRSM 97: 576-578 [Full Text]  
• Lader, E. W., Cannon, C. P., Ohman, E. M., Newby, L. K., Sulmasy, D. P., Barst, R. J., Fair, J. M., Flather, M., Freedman, J. E., Frye, R. L., Hand, M. M., Jesse, R. L., Van de Werf, F., Costa, F. (2004). The Clinician as Investigator: Participating in Clinical Trials in the Practice Setting: Appendix 1: Fundamentals of Study Design. Circulation 109: e302-e304 [Full Text]  
• Kilburn, B. B. (2004). Taking Issue: Pluralism and Casuistry in Bioethics. JAMA 291: 2131-2132 [Full Text]  
• Stirrat, G M (2004). Ethics and evidence based surgery. J. Med. Ethics 30: 160-165 [Abstract] [Full Text]  
• Heckerling, P. S. (2003). Ethical Aspects in Trials of Implantable Medical Devices. JAMA 290: 1579-1579 [Full Text]  
• Siderowf, A., Stern, M. (2003). Update on Parkinson Disease. ANN INTERN MED 138: 651-658 [Abstract] [Full Text]  
• Carpenter, W. T. Jr., Appelbaum, P. S., Levine, R. J. (2003). The Declaration of Helsinki and Clinical Trials: A Focus on Placebo-Controlled Trials in Schizophrenia. Am. J. Psychiatry 160: 356-362 [Abstract] [Full Text]  
• Rosser, A E, Barker, R A, Harrower, T, Watts, C, Farrington, M, Ho, A K, Burnstein, R M, Menon, D K, Gillard, J H, Pickard, J, Dunnett, S B (2002). Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475. J. Neurol. Neurosurg. Psychiatry 73: 678-685 [Abstract] [Full Text]  
• London, A. J., Kadane, J. B. (2002). Placebos that harm: sham surgery controls in clinical trials. Stat Methods Med Res 11: 413-427 [Abstract]  
• Albin, R L (2002). Sham surgery controls: intracerebral grafting of fetal tissue for Parkinson's disease and proposed criteria for use of sham surgery controls. J. Med. Ethics 28: 322-325 [Abstract] [Full Text]  
• Horng, S., Miller, F. G. (2002). Is Placebo Surgery Unethical?. NEJM 347: 137-139 [Full Text]  
• Kaptchuk, T. J. (2002). The Placebo Effect in Alternative Medicine: Can the Performance of a Healing Ritual Have Clinical Significance?. ANN INTERN MED 136: 817-825 [Abstract] [Full Text]  
• Moerman, D. E., Jonas, W. B. (2002). Deconstructing the Placebo Effect and Finding the Meaning Response. ANN INTERN MED 136: 471-476 [Abstract] [Full Text]  
• Clark, P. A. (2002). Placebo Surgery for Parkinson's Disease: Do the Benefits Outweigh the Risks?. J Law Med Ethics 30: 58-68  
• Strauss, R. P., Sengupta, S., Quinn, S. C., Goeppinger, J., Spaulding, C., Kegeles, S. M., Millett, G. (2001). The Role of Community Advisory Boards: Involving Communities in the Informed Consent Process. Am. J. Public Health 91: 1938-1943 [Abstract] [Full Text]  
• Olanow, C. W., Freeman, T., Kordower, J., Redmond, D. E. Jr., Sladek, J. R., Spencer, D. D., Freed, C. R., Breeze, R. E., Fahn, S. (2001). Transplantation of Embryonic Dopamine Neurons for Severe Parkinson's Disease. NEJM 345: 146-147 [Full Text]  
• Levine, S. B., Stagno, S. J. (2001). Informed Consent for Case Reports: The Ethical Dilemma of Right to Privacy Versus Pedagogical Freedom. J. Psychother. Pract. Res. 10: 193-201 [Abstract] [Full Text]  
• Dekkers, W., Boer, G. (2001). Sham neurosurgery in patients with Parkinson's disease: is it morally acceptable?. J. Med. Ethics 27: 151-156 [Abstract] [Full Text]  
• Menzel, C., Geiger, H., Sharma, A. M., Hohenbleicher, H. (2001). Neurovascular Contact of Cranial Nerve IX and X Root-Entry Zone in Hypertensive Patients Response. Hypertension 37 : e25-e25 [Full Text]  
• Fischbach, G. D., McKhann, G. M. (2001). Cell Therapy for Parkinson's Disease. NEJM 344: 763-765 [Full Text]  
• Lang, A. E. (2000). Surgery for Parkinson Disease: A Critical Evaluation of the State of the Art. Arch Neurol 57: 1118-1125 [Full Text]  
• Weiner, W. J., Burris, J. F., Freed, C. R., Breeze, R. E., Fahn, S., Slattery, J., Horisberger, J.-D., Freeman, T. B., Vawter, D. E., Olanow, C. W., Macklin, R. (2000). Placebo Surgery in Trials of Therapy for Parkinson's Disease. NEJM 342: 353-355 [Full Text]  
• Woodward, B. (1999). Challenges to Human Subject Protections in US Medical Research. JAMA 282: 1947-1952 [Abstract] [Full Text]